Insight

Veerle Geurts: Excellent outcome without chemotherapy for TNBC and high TILs

Photo of Veerle Geurts taken from www.avl.nl

Jun 30, 2024, 16:30

Veerle Geurts: Excellent outcome without chemotherapy for TNBC and high TILs

Veerle Geurts, PhD Candidate at The Netherlands Cancer Institute, shared on LinkedIn:

“Patients with stage I triple negative breast cancer and high TILs have excellent outcome without chemotherapy!

Excited to share our full publication, out now in JAMA oncology.

Thanks to all coauthors!”

Additional information.
Source: Veerle Geurts/LinkedIn

Angela DeMichele Antonio C. Wolff Breast Cancer cancer chemotherapy Gabe S. Sonke Hugo M. Horlings JAMA Oncology Marleen Ko Matthew P. Goetz MD Michail ignatiadis Natalie Klar OncoDaily Oncology Roberto A. Leon-Ferre Roberto Salgado Sabine C. Linn Sabine Siesling Sara Balduzzi Sherene Loi Stefan Michiels Sunil S. Badve Sylvia Adams Tessa G. Steenbruggen The Netherlands Cancer Institute TILs Veerle Geurts

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage